CD38 and neoplasm: Consistent with our findings, Moss laboratory utilized the CRISPR/Cas9 gene knockout of CD38 in A549 lung adenocarcinoma cells, which inhibited cell growth, cell invasion, and xenograft tumor growth in nude mice.8